Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease (2017)
- Authors:
- Autor USP: GUALANDRO, SANDRA FATIMA MENOSI - FM
- Unidade: FM
- DOI: 10.1056/NEJMoa1611770
- Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO; PLACEBO; DOENÇAS HEMATOLÓGICAS; EVENTO ADVERSO A MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: The New England Journal of Medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 376, n. 5, p. 429-439, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ATAGA, Kenneth I. et al. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. The New England Journal of Medicine, v. 376, n. 5, p. 429-439, 2017Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770. Acesso em: 18 fev. 2026. -
APA
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., et al. (2017). Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. The New England Journal of Medicine, 376( 5), 429-439. doi:10.1056/NEJMoa1611770 -
NLM
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 5): 429-439.[citado 2026 fev. 18 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770 -
Vancouver
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 5): 429-439.[citado 2026 fev. 18 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770 - Hemoglobinuria paroxistica noturna: a proposito de 11 casos
- Coronary flow velocity reserve is preserved in patients with sickle cell diasease and left ventricular hypertrophy
- Homocysteinemia and altered lipid profile in long term polyarticular onset juvenile idiopathic arthritis
- Anemia ferropênica
- Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
- Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia
- Anemias, megaloblásticas
- Hemocromatose
- Lipid profile, apoliproteins and homocysteine in long term polyarticular onset juvenile idiopathic arthritis
- Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
Informações sobre o DOI: 10.1056/NEJMoa1611770 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
